ع
Sections
  • Politics
  • Culture & Social Affairs
  • Business & Economy
  • Science & Technology
  • Documents & Memoirs
Regions
  • Gulf
  • MENA
  • Europe
  • USA
  • Asia
  • World
More
  • Videos
  • Cartoons
  • World in photos
  • Infographics
  • Profiles
  • Newsletter

LATEST ISSUE

Latest Issue
Magazine Archive
النسخة العربية
  • Politics
  • Culture & Social Affairs
  • Business & Economy
  • Science & Technology
  • Tag
  • Alzheimer

FILE - This Oct. 7, 2003 file photo shows a closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday, Nov. 29, 2022 - and the next question is how much difference that might make in people’s lives. Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better Alzheimer’s treatments. (AP Photo/David Duprey)

Drug Slows Alzheimer’s But Can It Make A Real Difference?

An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening — but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives. …

AP 30 November 2022
An Alzheimer's patient rests on a bench after a walk at the Village Landais Alzheimer site in Dax, France, September 24, 2020. Picture taken on September 24, 2020. REUTERS/Gonzalo Fuentes

Alzheimer's Drug Study Yields Positive Results, Say Makers Eisai and Biogen

An experimental Alzheimer's drug made by Eisai Co Ltd and Biogen slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday,…

28 September 2022
The Food and Drug Administration has approved the use of a drug to treat Alzheimer's disease. But multimodal therapies could be the best way to treat it.(TNS)

The key to Treating Alzheimer’s Disease May Not Be a Drug

My personal journey with Alzheimer’s began in 2005 when my wife, Valerie, received her diagnosis with this terrible disease, one that robs the afflicted of their minds and forces family and friends…

Leroy Hood 23 June 2021
  • Popular
  • Editor's Pick
Former military chief Gadi Eisenkot, leader of the Yashar party, waves an Israeli flag following the exit polls at his party headquarters, on the evening of Israel's national election, in Tel Aviv, Israel, on 28 October 2026. REUTERS/Shir Torem
Politics

Is Israel ready for its first non-Ashkenazi prime minister?

07, Nov 2026

Gadi Eisenkot, who may form a government, hails from a Moroccan-Jewish family. Israel's 15 prime ministers have all had European or Russian heritage. Is it time for a change?

Kamal Alam
Sara Padovan
Politics

The muted impact of electoral change on foreign policy

09, Nov 2026

Despite domestic shifts, new leaders often face structural constraints and have limited parameters to operate

Christopher Phillips
Pep Boatella
Science & Technology

Climate change is redrawing national borders

10, Nov 2026

Whether it is rivers, glaciers, or sea-level submergence, the implications of rising temperatures are becoming an increasingly urgent issue for states

Alaa Emara
Mohsen Rezaei attends a farewell ceremony on 3 July 2026 for Iran's late Supreme Leader Ayatollah Ali Khamenei, who was killed on 28 February in a US-Israel strike in Tehran. REUTERS/Mohammed Salem
Profiles

Mohsen Rezaei: the unlikely peacemaker

09, Nov 2026

The former IRGC general was recently appointed as secretary of the Supreme National Security Council. For the US, the danger is mistaking his prominence for a willingness to deliver concessions

Alex Vatanka
Culture & Social Affairs

Five Arab novels that paint an AI-dominated future

10, Nov 2026

From machines that develop human emotions to societies governed by artificial intelligence, Arab novelists explore the promises and perils of a radically transformed future

Ibrahim Adel

Sign up for the Weekly Newsletter

Get the best of Al Majalla, straight to your inbox.

Your newsletter subscriptions are subject to Al Majalla privacy policy and terms and conditions.

OPINIONS

Trump's midterm loss opens a window for Iran diplomacy

Alex Vatanka
Alex Vatanka

Syria: two controversies, one question

Alia Mansour
Alia Mansour

Britain's debt squeeze tests the pound’s power

Abdulfattah Khattab
Abdulfattah Khattab

US-Iran conflict: from diplomacy to all-out war

Al Majalla - London
Al Majalla - London
MORE FROM OPINIONS
logo
  • Politics
  • Culture & Social Affairs
  • Business & Economy
  • Science & Technology
  • Documents & Memoirs
  • Gulf
  • MENA
  • Europe
  • USA
  • Asia
  • World
  • Videos
  • Cartoons
  • World in photos
  • Infographics
  • Profiles
  • About Al Majalla
  • Al Majalla Team
  • Terms of Service
  • Privacy Policy
  • Contact us
logo

© Al Majalla Magazine. All Rights Reserved.

0:00:00
0:00:00